High-Resolution Sequencing Reveals Millions of Mutations in Wilms Tumor and Points to Immunotherapy

Utilizing single-cell nanorate sequencing, the study revealed extensive DNA alterations in Wilms tumors with a FOXR2 mutation poised to guide personalized therapies.